PRKG1 and neoplasm: -Enhances tumor cell proliferation, while inhibition activates cGMP/PKG signaling and blocks β-catenin nuclear translocation.-In NSCLC, PDE10A inhibition reduces proliferation by downregulating both Ras and Wnt pathways